Hereditary hemochromatosis, iron, hepcidin, and coronary heart disease

Area of Science:

• Cardiovascular Science
• Iron Metabolism
• Atherosclerosis Research

Background:

• Growing evidence links sustained iron depletion to protection against coronary heart disease (CHD).
• A key criticism questions iron's role in atherogenesis, citing the lack of prominent atherosclerosis in hereditary hemochromatosis.
• This challenges the iron hypothesis unless increased atherosclerosis is observed in hereditary hemochromatosis.

Purpose of the Study:

• To resolve the apparent paradox between iron's potential role in atherogenesis and the absence of increased atherosclerosis in hereditary hemochromatosis.
• To explore the implications of hepcidin physiology in understanding iron's role in cardiovascular disease.

Main Methods:

• Review of current evidence on iron depletion and CHD.
• Analysis of hereditary hemochromatosis pathophysiology.
• Examination of hepcidin's role in iron regulation and its potential impact on atherogenesis.

Main Results:

• Emerging details on hepcidin, the central hormone in iron regulation, offer a potential resolution.
• The study suggests iron's significant role in atherogenesis may exist even without increased plaque burden in hereditary hemochromatosis.

Conclusions:

• Hepcidin's physiology provides a framework to reconcile iron's role in atherogenesis with observations in hereditary hemochromatosis.
• Iron's impact on cardiovascular health, particularly atherogenesis, warrants further investigation considering hepcidin's regulatory functions.